Arbor Biotechnologies

This biotech aims to expand the CRISPR toolkit for more disease targets in the liver and brain
Pharma Voice
Tue, 12/19/23 - 10:29 am
Arbor Biotechnologies
gene editing
CRISPR
Vertex Leans into Gene Editing Space with Extended Arbor Pact
BioSpace
Thu, 01/12/23 - 10:41 am
Vertex Pharmaceuticals
Arbor Biotechnologies
gene editing
CRISPR-editing biotech Arbor Bio adds $215M for liver, CNS disease therapies
MedCity News
Wed, 11/10/21 - 10:17 am
Arbor Biotechnologies
MIT
liver disease
CNS disorders
funding
CRISPR
Why Vertex Is Expanding a Gene-Editing Partnership -- and It's not With CRISPR Therapeutics
Motley Fool
Mon, 09/6/21 - 09:03 pm
Vertex Pharmaceuticals
CRISPR
gene editing
Arbor Biotechnologies
Vertex boosts cell and genetic therapies toolkit in deal worth up to $1.2bn with Arbor
Biopharma Reporter
Mon, 08/30/21 - 10:57 am
Vertex
cell therapy
gene therapy
CRISPR
gene editing
Arbor Biotechnologies